Innovation and modern science are transforming women’s wellness

While women naturally outlive men globally, they spend 25% more of their total lives in poor health, enduring over a decade of preventable physical discomfort. For generations, medical research and clinical training overlooked female biology, leaving half the population with trial-and-error health solutions. Today, a major paradigm shift is underway. Groundbreaking advancements in longevity science, targeted clinical research, and specialized care are replacing outdated, one-size-fits-all models. By addressing key biological transitions—from early reproductive shifts to midlife hormonal resets—modern medicine is unlocking lifelong vitality. Driven by a $350 billion market demand, rising institutional support, and diverse healthcare leadership, this transformation ensures that living longer finally means living in full, vibrant health.

Read More

The Longevity Dividend

For affluent wealth owners, acting on the $9 trillion longevity megatrend requires a three-part playbook: systematically rebalance portfolios and wealth structures for extended lifespans; deploy capital into high-growth sectors like wellness real estate ($464bn), wellness tourism (+30% growth by 2028), and biotech; and optimize personal health span using advanced diagnostics—DNA sequencing, epigenetics, and metabolomics—combined with cellular therapies and daily lifestyle discipline. This pivots capital from material accumulation toward extended vitality, family well-being, and high-quality life experiences.

Read More

The GLP-1 effect: what happens after you stop being hungry?

The global expansion of GLP-1 therapies — such as Ozempic, Wegovy, and Mounjaro — is vastly misunderstood. This is not a pharmaceutical headline about weight loss or a clinical story — it is a $200 billion structural reallocation of global consumer capital. As biological hunger is systematically moderated across affluent markets, household expenditure is undergoing a permanent portfolio reset. Capital is fleeing volume-driven indulgence — processed foods, mass dining, and bulk alcohol — and compounding into a high-margin “longevity stack” centered on muscle preservation, real-time health intelligence, regenerative aesthetics, and vitality-focused luxury travel.

Read More

WEALTH & OTHER VICES #1. THE FRICTION PREMIUM

Money stopped being about things a long time ago. It buys time, access, privacy, health, experiences — and increasingly, the luxury of not having to deal with things you don't want to deal with. WEALTH & OTHER VICES is about what happens next. We write about money and investing, but not just markets; luxury, but not just watches and hotels; health, but without the green-juice sermon; technology, travel, property, food, people, pleasure and the increasingly strange ways affluent people choose to spend their money and their lives. We’re interested in what sits underneath the obvious story: where capital is moving, what wealthy people are suddenly willing to pay for, which habits are changing, and which businesses will benefit when they do. Some of it will make you money. Some of it will make you think. Some of it you may simply want. Welcome to W&OV.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

The Storm on Wall Street and the Great Restructuring: How Artificial Intelligence is Changing Wealth Management and Where We Are All Heading

The AI wealth-management boom didn’t start in September. It had been building quietly for most of the year. The numbers show just how quickly the market was expanding. The Wealth Mosaic’s AI WealthTech Market Map counted 497 companies working on AI-driven or AI-enhanced wealth-management solutions in December 2025. By January 2026 there were 517. February brought 536, March 554, May 581 and July 588. In other words, the tracked market added more than 90 companies in seven months. The change was not simply in the number of companies. The Wealth Mosaic reported a shift from experimentation toward practical deployment, with AI moving into adviser support, portfolio management, reporting, compliance, data management and operational workflows.

Read More